Effects of platelet-rich fibrin on healing of intra-bony defects treated with anorganic bovine bone mineral

• Main Authors: Yasemin SEZGIN, Ahu URAZ, I. Levent TANER, Rana ÇULHAOĞLU
• Format: Article
• Language: English
• Published: Sociedade Brasileira de Pesquisa Odontológica
• Series: Brazilian Oral Research
• Subjects: Periodontics; Alveolar Bone Loss; Bone Regeneration; Fibrin
• Online Access: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242017000100213&lng=en&tlng=en

Abstract Anorganic bovine bone mineral (ABBM) is extensively used in the treatment of intra-bony defects. Platelet-rich fibrin (PRF) is a new-generation platelet concentrate with a simplified technique. Although certain studies have reported the use of PRF in the treatment of intra-bony defects, to date, none of them have evaluated its additive effects with ABBM. Therefore, a randomised, split-mouth clinical trial was conducted to compare healing of intra-bony defects treated with an ABBM-PRF combination with healing of those treated with ABBM alone. By using a split-mouth design, 15 paired intra-bony defects were randomly treated with either ABBM alone (control group) or ABBM-PRF combination (test group). Following clinical parameters and radiographical measurements were recorded at baseline and 6 months after treatment: plaque index (PI), gingival index (GI), probing depth (PD), gingival recession (GR), clinical attachment level (CAL), vertical bone loss, depth of defect and defect angle. Preoperative clinical and radiographical measurements were similar for the test and control groups. Statistically significant reductions in GI, PD, CAL, vertical bone loss, depth of intra-bony defect and widening of defect angle were detected after treatment in both groups. With respect to inter-group analysis, gain in CAL was significantly greater in the test group than in the control group, whereas no inter-group differences were observed in any other parameter. The results of this study indicate that both therapies are effective in the treatment of intra-bony defects.